Figure 2From: Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donorsOverall survival in patients according to significant univariate analysis parameters. A, CRP < 0.8 VS > 0.8 mg/dl. B, IL-6 < 4 vs > 4 pg/ml.Back to article page